Imprimis Pharmaceuticals Stock Forecast

HROW Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, November 15, 2023, and so far it has risen 20.86%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Imprimis Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $11.34. On a fall, the stock will find some support from the short-term average at $9.52. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Maximize Your Market Edge: Go Premium for In-Depth AI-Powered Stock Research and Exclusive Lists! 🚀

Support, Risk & Stop-loss for Imprimis Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $8.60 and $8.21. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Imprimis Pharmaceuticals finds support just below today's level at $8.60. If this is broken, then the next support from accumulated volume will be at $8.21 and $8.10.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.270 between high and low, or 2.81%. For the last week, the stock has had daily average volatility of 3.53%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HROW) For The Upcoming Trading Day Of Monday 11th

For the upcoming trading day on Monday, 11th we expect Imprimis Pharmaceuticals to open at $9.77, and during the day (based on 14 day Average True Range), to move between $9.19 and $10.39, which gives a possible trading interval of +/-$0.596 (+/-6.09%) up or down from last closing price. If Imprimis Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.18% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $8.60, some $1.19 (12.16%) from the current price of $9.79, our system finds the risk reward attractive.

Is Imprimis Pharmaceuticals stock A Buy?

Imprimis Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.358 Open Broker Account

Remember To Visit Our YouTube Channel